Long-lasting alterations of the immune system by ionizing radiation exposure: Implications for disease development among atomic bomb survivors

References

• Akiyama M. Late effects of radiation on the human immune system: an overview of immune response among the atomic-bomb survivors. International Journal of Radiation Biology 1995; 68: 497–508
   PubMed Web of Science ®Google Scholar
• Akiyama M, Kusunoki Y, Kyoizumi S, Ozaki K, Mizuno S, Cologne J B. Study of the titers of anti-Epstein-Barr virus antibodies in the sera of atomic bomb survivors. Radiation Research 1993; 133: 297–302
   PubMed Web of Science ®Google Scholar
• Akiyama M, Yamakido M, Kobuke K, Dock D S, Hamilton H B, Awa A A, Kato H. Peripheral lymphocyte response to PHA and T cell population among atomic bomb survivors. Radiation Research 1983; 93: 572–580
   PubMed Web of Science ®Google Scholar
• Akiyama M, Zhou O L, Kusunoki Y, Kyoizumi S, Kohno N, Akiba S, Delongchamp R R. Age and dose related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors. Radiation Research 1989; 117: 26–34
   PubMed Web of Science ®Google Scholar
• Awa A A. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki. Journal of Radiation Research (Tokyo) 1991; 32(Suppl.)265–274
   PubMed Web of Science ®Google Scholar
• Bloom E T, Akiyama M, Korn E L, Kusunoki Y, Makinodan T. Immunological responses of aging Japanese A-bomb survivors. Radiation Research 1988; 116: 343–355
   PubMed Web of Science ®Google Scholar
• Cesari M, Penninx B W, Newman A B, Kritchevsky S B, Nicklas B J, Sutton-Tyrrell K, Tracy R P, Rubin S M, Harris T B, Pahor M. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). American Journal of Cardiology 2003; 92: 522–528
   PubMed Web of Science ®Google Scholar
• Cosmi L, Annunziato F, Galli M IG, Maggi R ME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. European Journal of Immunology 2000; 30: 2972–2979
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore J R, Pepys M B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 2000; 321: 199–204
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Carter R L, Akiyama M, Akahoshi M, Kodama K, Shimaoka K, Yamakido M. Autoantibodies and immunoglobulins among atomic bomb survivors. Radiation Research 1994; 137: 89–95
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiation Research 2000; 154: 12–19
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Sharp G B, Cologne J B, Kusumi S, Akahoshi M, Kodama K, Suzuki G, Yoshizawa H. Prevalence of hepatitis B virus infection among atomic bomb survivors. Radiation Research 2003; 159: 780–786
   PubMed Web of Science ®Google Scholar
• Goldrath A W, Bevan M J. Selecting and maintaining a diverse T-cell repertoire. Nature 1999; 402: 255–262
   PubMedGoogle Scholar
• Hakoda M, Akiyama M, Kyoizumi S, Awa A A, Yamakido M, Otake M. Increased somatic cell mutant frequency in atomic bomb survivors. Mutation Research 1988; 201: 39–48
   PubMed Web of Science ®Google Scholar
• Hakoda M, Hirai Y, Shimba H, Kusunoki Y, Kyoizumi S, Kodama Y, Akiyama M. Cloning of phenotypically different human lymphocytes originating from a single stem cell. Journal of Experimental Medicine 1989; 169: 1265–1276
   PubMed Web of Science ®Google Scholar
• Hakoda M, Kasagi F, Kusunoki Y, Matsuura S, Hayashi T, Kyoizumi S, Akahoshi M, Suzuki G, Kodama K, Fujiwara S. Levels of antibodies to microorganisms implicated in atherosclerosis and of C-reactive protein among atomic bomb survivors. Radiation Research 2006; 166: 360–366
   PubMed Web of Science ®Google Scholar
• Hayashi T, Fujiwara S, Morishita Y, Kusunoki Y, Nakashima E, Nakanishi S, Suzuki G, Nakachi K, Kyoizumi S. HLA haplotype is associated with diabetes among atomic bomb survivors. Human Immunology 2003a; 64: 910–916
   PubMed Web of Science ®Google Scholar
• Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, Kasagi F, Kodama K, Macphee D G, Kyoizumi S. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. International Journal of Radiation Biology 2003b; 79: 129–136
   PubMed Web of Science ®Google Scholar
• Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F, Hakoda M, Kyoizumi S, Nakachi K. Radiation dose-dependent aging of inflammatory status in association with enhanced humoral immunity in atomic bomb survivors. American Journal of Medicine 2005; 118: 83–86
   PubMed Web of Science ®Google Scholar
• Hirokawa K, Utsuyama M, Kasai M, Kurashima C. Aging and immunity. Acta Pathologica Japonica 1992; 42: 537–548
   PubMedGoogle Scholar
• Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S, Yamada M, Ejima E, Yokoyama N, Okubo M, Sugino K, Suzuki G, Maeda R, Nagataki S, Eguchi K. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. Journal of American Medical Association 2006; 295: 1011–1022
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nature Immunology 2004; 5: 987–995
   PubMed Web of Science ®Google Scholar
• Kato H, Mayumi M, Nishioka K, Hamilton H B. The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975 – 1977. American Journal of Epidemiology 1983; 117: 610–620
   PubMed Web of Science ®Google Scholar
• Kodama K, Fujiwara S, Yamada M, Kasagi F, Shimizu Y, Shigematsu I. Profiles of non-cancer diseases in atomic bomb survivors. World Health Statistics Quarterly 1996a; 49: 7–16
   PubMedGoogle Scholar
• Kodama K, Mabuchi K, Shigematsu I. A long-term cohort study of the atomic-bomb survivors. Journal of Epidemiology 1996b; 6: S95–105
   PubMedGoogle Scholar
• Koenig W, Sund M, Frohlich M, Fischer H G, Lowel H, Doring A, Hutchinson W L, Pepys M B. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237–242
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Akiyama M, Kyoizumi S, Bloom E T, Makinodan T. Age-related alteration in the composition of immunocompetent blood cells in atomic bomb survivors. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine 1988; 53: 189–198
   PubMedGoogle Scholar
• Kusunoki Y, Hayashi T, Morishita Y, Yamaoka M, Maki M, Bean M A, Kyoizumi S, Hakoda M, Kodama K. T-cell responses to mitogens in atomic bomb survivors: A decreased capacity to produce interleukin 2 characterizes the T cells of heavily irradiated individuals. Radiation Research 2001; 155: 81–88
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Kodama Y, Hirai Y, Kyoizumi S, Nakamura N, Akiyama M. Cytogenetic and immunologic identification of clonal expansion of stem cells into T and B lymphocytes in one Atomic-bomb survivor. Blood 1995; 86: 2106–2112
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Kyoizumi S, Hirai Y, Suzuki T, Nakashima E, Kodama K, Seyama T. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiation Research 1998; 150: 227–236
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Kyoizumi S, Yamaoka M, Kasagi F, Kodama K, Seyama T. Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction [published erratum appears in Radiation Research 2000 154:119]. Radiation Research 1999; 152: 539–543
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Yamaoka M, Kasagi F, Hayashi T, Koyama K, Kodama K, MacPhee D G, Kyoizumi S. T cells of atomic bomb survivors respond poorly to stimulation by Staphylococcus aureus toxins in vitro: Does this stem from their peripheral lymphocyte populations having a diminished naive CD4 T-cell content?. Radiation Research 2002a; 158: 715–724
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Hirai Y, Hakoda M, Kyoizumi S. Uneven distributions of naive and memory T cells in the CD4 and CD8 T-cell populations derived from a single stem cell in an atomic bomb survivor: Implications for the origins of the memory T-cell pools in adulthood. Radiation Research 2002b; 157: 493–499
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Yamaoka M, Kasagi F, Hayashi T, MacPhee D G, Kyoizumi S. Long-lasting changes in the T-cell receptor V beta repertoires of CD4 memory T-cell populations in the peripheral blood of radiation-exposed people. British Journal of Haematology 2003; 122: 975–984
   PubMed Web of Science ®Google Scholar
• Kuzmenok O, Potapnev M, Potapova S, Smolnikova V, Rzheutsky V, Yarilin A A, Savino W, Belyakov I M. Late effects of the Chernobyl radiation accident on T cell-mediated immunity in cleanup workers. Radiation Research 2003; 159: 109–116
   PubMed Web of Science ®Google Scholar
• Kyoizumi S, Nakamura N, Hakoda M, Awa A A, Bean M A, Jensen R H, Akiyama M. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Research 1989; 49: 581–588
   PubMed Web of Science ®Google Scholar
• Langlois R G, Bigbee W L, Kyoizumi S, Nakamura N, Bean M A, Akiyama M, Jensen R H. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 1987; 236: 445–448
   PubMed Web of Science ®Google Scholar
• Mackall C L, Fleisher T A, Brown M R, Andrich M P, Chen C C, Feuerstein I M, Magrath I, Wexler L H, Dimitrov D S, Gress R E. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89: 3700–3707
   PubMed Web of Science ®Google Scholar
• Mackall C L, Gress R E. Thymic aging and T-cell regeneration. Immunological Reviews 1997; 160: 91–102
   PubMed Web of Science ®Google Scholar
• Mackall C L, Punt J A, Morgan P, Farr A G, Gress R E. Thymic function in young/old chimeras: Substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. European Journal of Immunology 1998; 28: 1886–1893
   PubMed Web of Science ®Google Scholar
• Matsuo T, Nakashima E, Carter R L, Neriishi K, Mabuchi K, Akiyama M, Shimaoka K, Kinoshita K, Tomonaga M, Ichimaru M. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. Journal of Radiation Research 1995; 36: 8–16
   PubMed Web of Science ®Google Scholar
• Mendall M A, Strachan D P, Butland B K, Ballam L, Morris J, Sweetnam P M, Elwood P C. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. European Heart Journal 2000; 21: 1584–1590
   PubMed Web of Science ®Google Scholar
• Miller R A. The aging immune system: primer and prospectus. Science 1996; 273: 70–74
   PubMed Web of Science ®Google Scholar
• Morrison S J, Wandycz A M, Akashi K, Globerson A, Weissman I L. The aging of hematopoietic stem cells. Nature Medicine 1996; 2: 1011–1016
   PubMed Web of Science ®Google Scholar
• Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. Thyroid diseases among atomic bomb survivors in Nagasaki. Journal of American Medical Association 1994; 272: 364–370
   PubMed Web of Science ®Google Scholar
• Nakano M, Kodama Y, Ohtaki K, Itoh M, Awa A A, Cologne J, Kusunoki Y, Nakamura N. Estimating the number of hematopoietic or lymphoid stem cells giving rise to clonal chromosome aberrations in blood T lymphocytes. Radiation Research 2004; 161: 273–281
   PubMed Web of Science ®Google Scholar
• Neriishi K, Akiba S, Amano T, Ogino T, Kodama K. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiation Research 1995; 144: 215–221
   PubMed Web of Science ®Google Scholar
• Neriishi K, Nakashima E, Delongchamp R R. Persistent subclinical inflammation among A-bomb survivors. International Journal of Radiation Biology 2001; 77: 475–482
   PubMed Web of Science ®Google Scholar
• Ohkita T. Biological effects. A. Acute effects. In: A review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. Journal of Radiation Research (Tokyo) 1975; 16(Suppl.)49–66
   PubMedGoogle Scholar
• Oughtersen A W, Warren S. Hematology of atomic bomb injuries, pathology of atomic bomb injuries. Medical effects of the atomic bomb in Japan. National Nuclear Energy Series. Division III. McGraw-Hill, New York 1956; 191–430
   Google Scholar
• Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, Azen S. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002; 106: 2073–2077
   PubMed Web of Science ®Google Scholar
• Pawelec G, Solana R. Immunosenescence. Immunology Today 1997; 18: 514–516
   PubMedGoogle Scholar
• Pierce D A, Mendelsohn M L. A model for radiation-related cancer suggested by atomic bomb survivor data. Radiation Research 1999; 152: 642–654
   PubMed Web of Science ®Google Scholar
• Ridker P M, Cushman M, Stampfer M J, Tracy R P, Hennekens C H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 1997; 336: 973–979
   PubMed Web of Science ®Google Scholar
• Ridker P M, Rifai N, Stampfer M J, Hennekens C H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–1772
   PubMed Web of Science ®Google Scholar
• Ridker P M, Stampfer M J, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C- reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of American Medical Association 2001; 285: 2481–2485
   PubMed Web of Science ®Google Scholar
• Roesch W C. US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Radiation Effects Research Foundation, HiroshimaJapan 1987
   Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. New England Journal of Medicine 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Rufer N, Helg C, Chapuis B, Roosnek E. Human memory T cells: Lessons from stem cell transplantation. Trends in Immunology 2001; 22: 136–141
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann M M, Ristow M, Boeing H, Pfeiffer A F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52: 812–817
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Nakayama T. Recognition and function of Valpha14 NKT cells. Seminars in Immunology 2000; 12: 543–550
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Harrison L C. Antigen-induced regulatory T cells in autoimmunity. Nature Reviews, Immunology 2003; 3: 223–232
   PubMed Web of Science ®Google Scholar
• Watanabe N, De Rosa S C, Cmelak A, Hoppe R, Herzenberg L A, Roederer M. Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood 1997; 90: 3662–3672
   PubMed Web of Science ®Google Scholar
• Yamada M, Wong F L, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958 – 1998. Radiation Research 2004; 161: 622–632
   PubMed Web of Science ®Google Scholar
• Yamaoka M, Kusunoki Y, Kasagi F, Hayashi T, Nakachi K, Kyoizumi S. Decreases in percentages of naive CD4 and CD8 T cells and increases in percentages of memory CD8 T-cell subsets in the peripheral blood lymphocyte populations of A-bomb survivors. Radiation Research 2004; 161: 290–298
   PubMed Web of Science ®Google Scholar